keloid.
Conditions
Interventions
Intervention group: Patients with refractory keloids referred to the dermatology clinic of Loghman Hakim and Shohada Tajrish hospitals will be treated with intra-lesional of bleomycincin 5 mg and tria
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients between the ages of 18 and 60 Refractory keloid: Relapse or not cured despite six sessions of intra-triamcyonolone acetonide injection.
Exclusion criteria
Exclusion criteria: Dissatisfaction with the study sensitivity to bleomycin pregnant or breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the efficacy of keloid treatment by intralesional injection of bleomycin in combination with intralesion injection of triamcinolone.(pigmentation, vascularity, pliability and thickness). Timepoint: The Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: The VSS (Vancouver Scar Scale) scale and examining the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Relapse rate. Timepoint: Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: The VSS (Vancouver Scar Scale) scale.;Complication of treatment. Timepoint: Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: observation and asking for the patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaeghe Mollaabasi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed